Last edition
News about "pTau217 antibody "
ALZpath Signs Licensing Deal with Roche for Use of pTau217 Antibody in Blood Test
ALZpath, Inc. has signed a strategic license agreement with Roche for the use of the ALZpath pTau217 antibody to develop and commercialize an Alzheimer's disease diagnostic blood test.
PTau217 Antibody | 11/06/2024 | By Aishwarya | 252
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members